Advertisement
Advertisement
U.S. markets close in 5 hours 32 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NanoVibronix, Inc. (NAOV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4804-0.0596 (-3.87%)
As of 10:26AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close1.5400
Open1.5300
Bid1.4800 x 1800
Ask1.4900 x 1800
Day's Range1.4400 - 1.5450
52 Week Range0.5400 - 4.1900
Volume545,189
Avg. Volume22,274,606
Market Cap35.692M
Beta (5Y Monthly)0.17
PE Ratio (TTM)N/A
EPS (TTM)-0.3740
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NAOV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NanoVibronix, Inc.
    Analyst Report: Zimmer Biomet Holdings, Inc.Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Close to 60% of total revenue is derived from sales of large joints, another 22% comes from extremities and trauma; the remaining portion is primarily related to spine and dental products.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • Benzinga

    NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain

    NanoVibronix Inc (NASDAQ: NAOV) has announced results from a randomized, double-blind study to evaluate the safety and effectiveness of the NanoVibronix PainShield. Related: NanoVibronix Launches CBD-Based Product For Pain Management. Patients in the study were being treated by an orthopedic surgeon Patients in the study were being treated for Lateral epicondylitis (tennis elbow) patients, swelling or tearing of the tendons in the arm. All patients had been following customary treatment guidance

  • GlobeNewswire

    NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD

    Study Finds PainShield Device is Safe and Effective in the Treatment of Tennis ElbowElmsford, NY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive results from a randomized, double-blind study conducted at Birmingham Orthopedic and Sports Specialists in Birmingham, Alabama. Clinicians at Birmingham Orthopedic a

  • GlobeNewswire

    NANOVIBRONIX ENTERS WORKER’S COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL

    Signs Provider Participation Agreement with a Leading, National Payer;Increases Access to PainShield® for Eligible Beneficiaries Covered Under a Worker’s Comp PlanElmsford, NY, Sept. 29, 2021 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered the worker’s compensation market with the signing of a Provider Participation A

Advertisement
Advertisement